6MB0
Crystal structure of N-myristoyl transferase (NMT) G386E mutant from Plasmodium vivax in complex with inhibitor IMP-1002
6MB0 の概要
| エントリーDOI | 10.2210/pdb6mb0/pdb |
| 分子名称 | Glycylpeptide N-tetradecanoyltransferase, TETRADEC-13-YNOIC ACID - COA THIOESTER, 1-(5-{4-fluoro-2-[2-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethoxy]phenyl}-1-methyl-1H-indazol-3-yl)-N,N-dimethylmethanamine, ... (7 entities in total) |
| 機能のキーワード | ssgcid, glycylpeptide n-tetradecanoyltransferase, n-myristoyltransferase, nmt, salvador i, structural genomics, seattle structural genomics center for infectious disease, transferase |
| 由来する生物種 | Plasmodium vivax |
| タンパク質・核酸の鎖数 | 3 |
| 化学式量合計 | 146619.83 |
| 構造登録者 | Seattle Structural Genomics Center for Infectious Disease (SSGCID) (登録日: 2018-08-29, 公開日: 2019-06-05, 最終更新日: 2024-03-13) |
| 主引用文献 | Schlott, A.C.,Mayclin, S.,Reers, A.R.,Coburn-Flynn, O.,Bell, A.S.,Green, J.,Knuepfer, E.,Charter, D.,Bonnert, R.,Campo, B.,Burrows, J.,Lyons-Abbott, S.,Staker, B.L.,Chung, C.W.,Myler, P.J.,Fidock, D.A.,Tate, E.W.,Holder, A.A. Structure-Guided Identification of Resistance Breaking Antimalarial N‐Myristoyltransferase Inhibitors. Cell Chem Biol, 26:991-, 2019 Cited by PubMed Abstract: The attachment of myristate to the N-terminal glycine of certain proteins is largely a co-translational modification catalyzed by N-myristoyltransferase (NMT), and involved in protein membrane-localization. Pathogen NMT is a validated therapeutic target in numerous infectious diseases including malaria. In Plasmodium falciparum, NMT substrates are important in essential processes including parasite gliding motility and host cell invasion. Here, we generated parasites resistant to a particular NMT inhibitor series and show that resistance in an in vitro parasite growth assay is mediated by a single amino acid substitution in the NMT substrate-binding pocket. The basis of resistance was validated and analyzed with a structure-guided approach using crystallography, in combination with enzyme activity, stability, and surface plasmon resonance assays, allowing identification of another inhibitor series unaffected by this substitution. We suggest that resistance studies incorporated early in the drug development process help selection of drug combinations to impede rapid evolution of parasite resistance. PubMed: 31080074DOI: 10.1016/j.chembiol.2019.03.015 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.55 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






